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doi.org/10.1016/j.ijmyco.2016.08.017Several studies have been done in relation to recurrence of tuberculosis (TB) following
completion of treatment. However, recurrence of TB is still a major problem from a public
health perspective in high-burden countries, where no special attention is being given to
this issue. Disease recurrence is an important indicator of the efficacy of antituberculosis
treatment. The rate of recurrence is highly variable and has been estimated to range from
4.9% to 25%. This variability is not only a reflection of regional epidemiology of recurrence
but differences in the definitions used by the TB control programs. In addition to treatment
failure related to medication adherence, there are several key host factors that are
associated with high rates of recurrence. The widely recognized host factors independent
of treatment program that predispose to TB recurrence include: malnutrition; human
immunodeficiency virus; substance abuse including tobacco use; comorbidity such as
diabetes, renal failure and systemic diseases, especially immunosuppressive states; and
environmental exposure such as silicosis. With improved understanding of the human
genome, proteome, and metabolome, additional host-specific factors that predispose to
recurrence are being discovered. Information on temporal and geographical trends of TB
cases as well as genotyping might provide further information to enable us to fully
understand TB recurrence and discriminate between reactivation and new infection. The
recently launched World Health Organization End TB Strategy emphasizes the importance
of integrated, patient-centered TB care. Continued improvement in diagnosis, treatment
approaches, and defining host-specific factors are needed to fully understand the clinical
epidemiological and social determinants of TB recurrence.Conflicts of interest
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